A CC' loop decoy peptide blocks the interaction between Act1 and IL-17RA to attenuate IL-17- and IL-25-induced inflammation.
A CC' loop decoy peptide blocks the interaction between Act1 and IL-17RA to attenuate IL-17- and IL-25-induced inflammation.
复制标题
DOI:
10.1126/scisignal.2001843
复制
发表时间:
2011-11-01
影响因子:
7.3
通讯作者:
Li X
中科院分区:
文献类型:
--
作者:
Liu C;Swaidani S;Qian W;Kang Z;Sun P;Han Y;Wang C;Gulen MF;Yin W;Zhang C;Fox PL;Aronica M;Hamilton TA;Misra S;Deng J;Li X
Interleukin-17 (IL-17) and IL-25 signaling induce the expression of genes that encode inflammatory factors and they are implicated in the pathology of various inflammatory diseases. Nuclear factor κB (NF-κB) activator 1 (Act1) is an adaptor protein and E3 ubiquitin ligase that is critical for IL-17 and IL-25 signaling, and it is recruited to their receptors through heterotypic interactions between their SEFIR [SEF (similar expression to fibroblast growth factor genes)/IL-17R] domains. Modeling of SEFIR domains has shown their structural similarity with the Toll-IL-1 receptor (TIR) domains of Toll-like receptors (TLRs) and the IL-1R. Whereas the BB′ loop of TIR is required for TIR-TIR interactions, we found that deletion of the BB′ loop from Act1 or IL-17RA (a common subunit of IL-17R and IL-25R) did not affect Act1–IL-17RA interactions. Instead, deletion of the CC′ loop from Act1 or IL-17RA abolished the interaction between Act1 and IL-17RA, suggesting that SEFIR and TIR domains interact in different manners. Surface plasmon resonance measurements showed that a peptide corresponding to the CC′ loop bound directly to IL-17RA. A cell-permeable decoy peptide based on the CC′ loop sequence inhibited IL-17- and IL-25-mediated signaling, and it inhibited IL-17- and IL-25-induced responses in vitro and pulmonary inflammation in vivo. Together, these findings provide the molecular basis for the specificity of SEFIR versus TIR domain interactions and consequent signaling. Moreover, we suggest that the CC′ loop motif of SEFIR domains is a promising target for therapeutic strategies against IL-17- and IL-25-asssociated inflammatory diseases.
登录
查看更多内容
影响因子:
4.4
作者:
Claudio, Estefania;Sonder, Soren Ulrik;Saret, Sun;Carvalho, Gabrielle;Ramalingam, Thirumalai R.;Wynn, Thomas A.;Chariot, Alain;Garcia-Perganeda, Antonio;Leonardi, Antonio;Paun, Andrea;Chen, Amy;Ren, Nina Y.;Wang, Hongshan;Siebenlist, Ulrich
通讯作者:
Siebenlist, Ulrich
DOI:
10.4049/jimmunol.182.3.1631
发表时间:
2009-02-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Swaidani S;Bulek K;Kang Z;Liu C;Lu Y;Yin W;Aronica M;Li X
通讯作者:
Li X
影响因子:
30.5
作者:
Qian, Youcun;Liu, Caini;Li, Xiaoxia
通讯作者:
Li, Xiaoxia
影响因子:
14.8
作者:
通讯作者:
--
DOI:
10.1084/jem.20061401
发表时间:
2006-11-27
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Schnyder-Candrian S;Togbe D;Couillin I;Mercier I;Brombacher F;Quesniaux V;Fossiez F;Ryffel B;Schnyder B
通讯作者:
Schnyder B